WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'1101 Infant (under 12 months) mortality rate: 762
GDP / capita (US$): 2'6031 Child (under 5 years) mortality rate: 1122

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 3'796  3'703  3'609  3'516  3'423  2'708  2'024  1'534 
Births 131  129  127  125  123  104  83  66 
Surviving infants 121  120  118  116  114  96  76  60 
Pop. less than 5 years 575  565  553  543  533  443  350  273 
Pop. less than 15 years 1'529  1'497  1'464  1'434  1'404  1'159  903  696 
Female 15-49 years 920  897  874  849  825  636  461  346 

Number of reported case

(Click for retrospective incidence data for Mauritania)
Diphtheria 18 
Japanese encephalitis
Measles 35  234  1'292  322  1'379  11'441 
Mumps
Pertussis 30  383  7'576 
Polio* 13  159 
Rubella 10 
Rubella (CRS)
Tetanus (neonatal) 16 
Tetanus (total) 24  12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritania)
Vaccine year result method % card seen                                                
BCG 2006  86  MICS   32.3  95  86  85  81  89  48  79 
DTP1 2006  83  MICS   32.3  95  91  82  79  88 
DTP3 2006  57  MICS   32.3  80  75  64  64  74  31  33 
HepB_BD          88 
HepB3 2006  25  MICS   32.3  80  75  64  64  74 
Hib3          80  75  64  64 
JapEnc         
MCV 2006  76  MICS   32.3  75  67  67  59  65  38 
MCV2         
PCV1         
PCV3         
Pol3 2006  46  MICS   32.3  80  73  52  63  73  31  33 
Rota1         
Rota_last         
Rubella1         
TT2plus 2003  67  EPI   42.0  40  29  30  29  30  15 
PAB         
VAD1         
YFV 1988  36  EPI   69.0  32 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritania)
BCG 95  86  85  81  89  78  79 
DTP1 95  91  82  79  88  73  69 
DTP3 80  75  64  64  74  51  33 
HepB3 80  75  64  64  74 
Hib3 80  75  64  64 
MCV 75  67  67  59  65  46  38 
PAB 80  80  87  87  77  44  24 
PCV3
Pol3 80  73  52  63  73  58  33 
Rota_last
YFV

Number of districts in the country 53  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 15
From 80 to 89% 25
From 50 to 79% 47
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_ps Yes From October 2013
TT 1st contact or pregnancy; +1, +6 months;+1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 
What years does the MYP cover? number 2012-2015  2012-2015  2008-2012  2008-2012      2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 53  39  39         

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  Yes  Yes         

System performance

Total number of districts in country number 53  53  53  53  53  53  53 
Nº districts with DTP3 coverage >=80% number 21  15  12  18  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 40  28  17  11  23  34  21 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%    

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 15  21  11  100    100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.